Skip to main content

Can Aricept be stopped abruptly?

Medically reviewed by Kristianne Hannemann, PharmD. Last updated on March 25, 2025.

Official Answer by Drugs.com

No, you should not stop taking Aricept (donepezil) suddenly without consulting your healthcare provider. Abruptly discontinuing Aricept may cause a worsening of Alzheimer’s disease symptoms. Instead, your healthcare provider may recommend gradually reducing the dosage to minimize potential risks.

What Happens If You Stop Aricept Suddenly?

Clinical studies show that discontinuing Aricept leads to a loss of its benefits:

When Should You Stop Taking Aricept?

Your healthcare provider may advise stopping Aricept in certain situations, such as:

Related questions

How to Stop Aricept Safely

If you need to stop taking Aricept, do not adjust the dosage on your own. Your doctor or other healthcare provider will help create a plan to taper the medication safely while monitoring for any worsening symptoms. If symptoms reappear, they may consider restarting Aricept before attempting another gradual reduction.

Always consult your healthcare provider before making any changes to your medication regimen.

References

Bidzan, L., et. al. (2012). Withdrawal syndrome after donepezil cessation in a patient with dementia. In: Neurological Sciences. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506829/

Burns, A., et al. (1999). The effects of donepezil in Alzheimer's disease - results from a multinational trial. In: Dementia and Geriatric Cognitive Disorders. Available from: https://pubmed.ncbi.nlm.nih.gov/10325453/

Donepezil tablet [package insert]. (Revised April 2023). Camber Pharmaceuticals, Inc. Accessed 06/14/2024 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=11ac01f4-d26e-47b2-9660-d514ab097fdb

Howard, R., et. al. (2012). Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease. In: The New England Journal of Medicine. Available from: https://pubmed.ncbi.nlm.nih.gov/22397651/

Kueper, J., et. al. (2018). The Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review. In: Journal of Alzheimer’s Disease. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929311/

Reeve, E., et. al. (2019). Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary. In: The Medical Journal of Australia. Available from: https://onlinelibrary.wiley.com/doi/full/10.5694/mja2.50015

Rogers, S. L., et. al. (1998). Donepezil Improves Cognition and Global Function in Alzheimer Disease: A 15-Week, Double-blind, Placebo-Controlled Study. In: JAMA. Available from: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/205223

Read next

How does Aricept work?

Aricept belongs to a class of drugs called cholinesterase inhibitors, which work by increasing acetylcholine levels to support better brain function. However, it does not change the progression of dementia itself. Continue reading

What is Quercetin and what are its health benefits?

Quercetin is an antioxidant and belongs to a group of plant pigments called flavonoids. It is found naturally in many fruits, vegetables, flowers, bark, and leaves but is not made in the human body. Studies show quercetin may help to protect against many health conditions associated with oxidative stress, including heart disease, rheumatoid arthritis and cancer. Continue reading

What is the controversy surrounding Leqembi?

Leqembi (lecanemab-irmb), a medication designed to treat Alzheimer's disease, has been a subject of considerable controversy. The primary points of debate revolve around its effectiveness, safety, and cost. Continue reading

See also:

Related medical questions

Drug information

Related support groups